Key points from article :
Nilotinib has been used to treat patients with a certain type of leukaemia.
Works by boosting the ability to clear out proteins which accumulate in the brain.
Small clinical trial (12 people) tested on patients with Parkinson’s disease.
Some participants began talking again.
One individual who had been confined to a wheelchair was able to walk again.
